Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Terminado
Fase 2
ClinicalTrials.gov
A Phase 2, Open-Label, Randomized, Multicenter Trial of Encorafenib + Binimetinib Evaluating a Standard-dose and a High-dose Regimen in Patients With BRAFV600-Mutant Melanoma Brain Metastasis
INTERVENTIONAL
Inicio: 30 de abr de 2019
ID: NCT03911869
Terminado
Fase 3
ClinicalTrials.gov
An Open-Label, Long-Term Safety Study Including a Double-Blind, Placebo-Controlled, Randomized Withdrawal Period of TEV-50717 (Deutetrabenazine) for the Treatment of Tourette Syndrome in Children and Adolescents
INTERVENTIONAL
Inicio: 25 de may de 2018
ID: NCT03567291
Reclutando
Fase 3
ClinicalTrials.gov
A Phase 3 Study to Investigate the Safety, Tolerability, and Immunogenicity of Revaccinating Pregnant Participants During Subsequent Pregnancies and Persistence of Immunity of a Single Dose of a Bivalent Respiratory Syncytial Virus (RSV) Vaccine.
INTERVENTIONAL
Inicio: 16 de abr de 2025
ID: NCT06866405
Completado
Fase 3
ClinicalTrials.gov
A Multicentre, Randomised, Double-blind, Placebo-controlled, Phase 3 Study Evaluating the Efficacy and Safety of Anifrolumab in Adult Subjects With Active Systemic Lupus Erythematosus
INTERVENTIONAL
Inicio: 9 de jul de 2015
ID: NCT02446899
Completado
Fase 3
ClinicalTrials.gov
COMBI-APlus: Open-label, Phase IIIb Study of Dabrafenib in COMBInation With Trametinib in the Adjuvant Treatment of Stage III BRAF V600 Mutation-positive Melanoma After Complete Resection to Evaluate the Impact on Pyrexia Related Outcomes of an Adapted Pyrexia AE-management Algorithm (Plus)
INTERVENTIONAL
Inicio: 29 de ago de 2018
ID: NCT03551626
Completado
Fase 3
ClinicalTrials.gov
AN INTERVENTIONAL EFFICACY AND SAFETY, PHASE 2/3, DOUBLE-BLIND, 2-ARM STUDY TO INVESTIGATE ORALLY ADMINISTERED PF-07321332/RITONAVIR COMPARED WITH PLACEBO IN NONHOSPITALIZED SYMPTOMATIC ADULT PARTICIPANTS WITH COVID-19 WHO ARE AT INCREASED RISK OF PROGRESSING TO SEVERE ILLNESS
INTERVENTIONAL
Inicio: 16 de jul de 2021
ID: NCT04960202
Reclutando
Fase 3
ClinicalTrials.gov
A Phase 3 Randomized, Open-Label, Multicenter Study of Sonrotoclax Plus Anti-CD20 Antibody Therapies Versus Venetoclax Plus Rituximab in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
INTERVENTIONAL
Inicio: 11 de jun de 2025
ID: NCT06943872
Terminado
Fase 2
ClinicalTrials.gov
A Two-arm Randomized Open Label Phase 2 Study Of Cp-751,871 In Combination With Exemestane Versus Exemestane Alone As First Line Treatment For Postmenopausal Patients With Hormone Receptor Positive Advanced Breast Cancer
INTERVENTIONAL
Inicio: 1 de feb de 2007
ID: NCT00372996
Completado
Fase 3
ClinicalTrials.gov
A 12-week Double-blind, Randomized, Multi-center Study Comparing the Efficacy and Safety of Once Monthly Subcutaneous AMG 334 Against Placebo in Adult Episodic Migraine Patients (EMPOwER)
INTERVENTIONAL
Inicio: 8 de feb de 2018
ID: NCT03333109
Completado
Fase 4
ClinicalTrials.gov
A Phase 4, Non-treatment Follow-up For Cardiac Assessments Following Use Of Smoking Cessation Treatments In Subjects With And Without A History Of Psychiatric Disorders
INTERVENTIONAL
Inicio: 1 de may de 2012
ID: NCT01574703
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study of Bendamustine and Rituximab (BR) Alone Versus in Combination With Acalabrutinib (ACP-196) in Subjects With Previously Untreated Mantle Cell Lymphoma
INTERVENTIONAL
Inicio: 5 de abr de 2017
ID: NCT02972840
Activo, no recluta
Fase 3
ClinicalTrials.gov
Adjuvant Encorafenib & Binimetinib vs. Placebo in Fully Resected Stage IIB/C BRAF V600E/K Mutated Melanoma: a Randomized Triple-blind Phase III Study in Collaboration With the EORTC Melanoma Group
INTERVENTIONAL
Inicio: 2 de may de 2022
ID: NCT05270044
Terminado
Fase 3
ClinicalTrials.gov
A Phase 3, Multicentre, Double-masked, Randomised Study to Evaluate the Efficacy and Safety of Intravitreal OPT-302 in Combination With Aflibercept, Compared With Aflibercept Alone, in Participants With nAMD
INTERVENTIONAL
Inicio: 12 de mar de 2021
ID: NCT04757636
Activo, no recluta
RENIS
delirios asociados con la psicosis de la enfermedad de Alzheimer
INTERVENTIONAL
ID: IS005270
Aún no recluta
RENIS
J2A-MC-GZPR: Eficacia y seguridad de orforglipron en participantes con enfermedad arterial periférica
INTERVENTIONAL
ID: IS005269
Aún no recluta
RENIS
J6M-MC-JSGD: Estudio de tersolisib (LY4064809/STX-478) con otros tratamientos contra el cáncer en participantes con cáncer de mama avanzado con una mutación genética (PIK3CA)
INTERVENTIONAL
ID: IS005267
Aún no recluta
RENIS
J3R-MC-YDAF:Un estudio de eloralintida en participantes con obesidad o sobrepeso, y diabetes tipo 2
INTERVENTIONAL
ID: IS005266
Aún no recluta
RENIS
Estrategias comunicativas del personal de enfermería en emergencias pediátricas con padres o acompañantes.
OBSERVATIONAL
ID: IS005264
Aún no recluta
RENIS
Criterios de valoración y estrategias de manejo del dolor en pacientes pediátricos aplicadas por profesionales de enfermería del sector Clínica I del Hospital Pediátrico Dr. Fernando Barreyro de Posadas, Misiones, 2026
OBSERVATIONAL
ID: IS005262
Aún no recluta
RENIS
J3R-MC-YDAN: Eficacia y seguridad de eloralintida en participantes con dolor de rodilla por osteoartritis, y obesidad o sobrepeso
INTERVENTIONAL
ID: IS005259
Anterior
1
...
9
10
11
...
434
Siguiente
Filtros